Edgar Tracker

CORT CORCEPT THERAPEUTICS INC

Nasdaq · CIK 1088856 · Pharmaceutical Preparations

SEC company page

Public articles

CORT · 10-Q

Filing note · 10-Q · filed 2026-07-29

AI summary · GPT 4o mini · full Executive summary Corcept Therapeutics CORT reported strong Q2 2026 financial results with significant revenue growth, driven by the launch of Lify…

Recent filings

–

Form Filed Title Accession
SCHEDULE 13G/A2026-10-27—0002012383-26-003888
32026-10-0530001193125-26-414633
8-K2026-09-235.02 Departure/Election of Directors or Principal Officers · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits0001193125-26-398561
32026-09-0330001193125-26-382432
SCHEDULE 13G/A2026-08-13—0001037389-26-000048
10-Q2026-07-2910-Q Article0001628280-26-050613
8-K2026-07-292.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits0001628280-26-050607
8-K2026-06-178.01 Other Events · 9.01 Financial Statements and Exhibits0001193125-26-274258
8-K2026-06-038.01 Other Events0001193125-26-254622
S-82026-05-29S-80001193125-26-248419
8-K2026-05-285.02 Departure/Election of Directors or Principal Officers · 5.07 Submission of Matters to a Vote of Security Holders · 9.01 Financial Statements and Exhibits0001628280-26-038793
10-Q2026-04-3010-Q0001628280-26-028902
8-K2026-04-302.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits0001628280-26-028892
SCHEDULE 13G/A2026-04-21—0001041885-26-000003
DEF 14A2026-04-17DEF 14A0001628280-26-025735
SCHEDULE 13G/A2026-03-26—0000102909-26-001092
8-K2026-03-258.01 Other Events · 9.01 Financial Statements and Exhibits0001193125-26-123543
10-K2026-02-2410-K0001628280-26-011091
8-K2026-02-242.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits0001628280-26-011080
8-K2026-02-198.01 Other Events · 9.01 Financial Statements and Exhibits0001193125-26-059551